# Celecoxib in Preventing Skin Cancer

> **NCT00025051** · PHASE2 · WITHDRAWN · sponsor: **National Cancer Institute (NCI)**

## Conditions studied

- Non-melanomatous Skin Cancer

## Interventions

- **DRUG:** celecoxib
- **PROCEDURE:** anti-cytokine therapy
- **PROCEDURE:** antiangiogenesis therapy
- **PROCEDURE:** biological therapy
- **PROCEDURE:** cancer prevention intervention
- **PROCEDURE:** chemoprevention of cancer
- **PROCEDURE:** growth factor antagonist therapy

## Key facts

- **NCT ID:** NCT00025051
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00025051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00025051, "Celecoxib in Preventing Skin Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00025051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*